Mouse Models of Intestinal Cancer
(Reprinted
with permission from Boivin et al., 2003)
|
Name of Model
|
Background Strain
|
Predominant Location
|
Predominant Neoplasm
|
Average Number of Tumors/ Mouse
|
Age when
Analyzed
|
Other lesions
|
Metastasis
|
Reference
|
|
WNT Pathway
|
|
|
|
|
|
|
|
|
|
ApcMin/+
|
C57BL/6
|
Small Intestine
|
Adenoma
|
30
|
4 months
|
carcinoma
|
no
|
61
|
|
Apc1638N/+
|
C57BL/6
|
Small Intestine
|
Adenoma/Carcinoma
|
4
|
12 months
|
desmoid tumors
|
Yes (1 reported)
|
78, 64
|
|
ApcD716/+
|
C57BL/6
|
Small Intestine
|
Adenoma
|
300
|
4 months
|
|
no
|
63
|
|
Apc1309/+
|
NR
|
Small Intestine
|
Adenoma
|
34
|
3 months
|
|
no
|
98
|
|
DN131 b-catenin
|
C57BL/6 x DBA
|
Small Intestine
|
Adenoma
|
1
|
1 month
|
polycystic renal disease
|
no
|
66
|
|
Activated b-catenin
|
C57BL/6 x NR
|
Small Intestine
|
Adenoma
|
3000
|
1 month
|
|
no
|
68
|
|
Mismatch repair genes
|
|
|
|
|
|
|
|
|
|
Msh3-/-
|
C57BL/6 x 129/Sv x SJL/J
|
Small Intestine
|
Adenoma/Carcinoma
|
<1
|
24 months
|
lymphomas, skin tumors
|
no
|
72
|
|
Msh3-/- Apc1638/+
|
C57Bl/6
|
Small/large intestine
|
Adenoma/Carcinoma
|
5
|
9 months
|
skin tumor
|
no
|
80
|
|
Msh6-/-
|
C57BL/6 x 129/SvJ x SJL/J
|
Small Intestine
|
Adenoma/Carcinoma
|
<1
|
11 months
|
lymphomas, skin tumors
|
no
|
73
|
|
Msh6-/- Apc1638/+
|
C57Bl/6
|
Small/Large Intestine
|
Adenoma/Carcinoma
|
26
|
5 months
|
skin tumor
|
no
|
80
|
|
Msh3-/- Msh6-/-
|
129/Ola x FVB/N
|
Small Intestine
|
Adenoma/Carcinoma
|
1
|
6 months
|
skin tumor
|
no
|
72
|
|
Msh3-/-Msh6-/-Apc1638/+
|
C57Bl/6
|
Small/Large Intestine
|
Adenoma/Carcinoma
|
40
|
<3 months
|
|
no
|
80
|
|
Mlh1-/-
|
C57BL/6 x 129/Ola
|
Small Intestine
|
Adenoma/Carcinoma
|
2
|
6 months
|
lymphomas, skin tumors
|
no
|
88
|
|
Mlh1+/- Apc1638/+
|
C57Bl/6
|
Small Intestine
|
Adenoma/Carcinoma
|
2
|
6 months
|
skin tumor
|
no
|
88
|
|
Mlh1-/- Apc1638/+
|
C57BL/6 x 129/Ola
|
Small Intestine
|
Adenoma/Carcinoma
|
45
|
3 months
|
|
no
|
88
|
|
Mlh1-/- ApcMin/+
|
C57BL/6
|
Small Intestine
|
Adenoma
|
139
|
2 months
|
|
no
|
89
|
|
Msh2-/-
|
C57BL/6 x 129/Ola
|
Small Intestine
|
Adenoma/Carcinoma
|
<1
|
6 months
|
lymphoma
|
no
|
71
|
|
TGFb models
|
|
|
|
|
|
|
|
|
|
Rag2-/- Tgfb1-/-
|
129S6 x CF1
|
Cecum/Colon
|
Mucinous Carcinoma
|
2
|
2-6 months
|
|
no
|
77
|
|
Rag2-/- Tgfb1+/-
|
129S6 x CF1
|
Cecum/Colon
|
Adenoma
|
2
|
2-6 months
|
|
no
|
77
|
|
Smad4+/-
|
C57BL/6
|
Stomach/
Duodenum
|
Hamartomatous Polyp
|
2
|
24 months
|
|
No
|
84
|
|
Smad4+/- ApcD716/+
|
C57BL/6
|
Small Intestine
|
Carcinoma
|
300
|
4 months
|
signet ring cell carcinoma
|
|
84
|
|
Smad3-/-
|
129/Sv
|
Colon
|
Mucinous Carcinoma
|
NR
|
6 months
|
rectal prolapse
|
yes
|
83
|
|
Smad3-/-
|
129 x C57BL/6
|
Cecum/Colon
|
Mucinous Carcinoma
|
NR
|
NR
|
rectal prolapse
|
NR
|
83
|
|
Immunodeficient
|
|
|
|
|
|
|
|
|
|
Il-10-/-
|
C57BL/6 x 129
|
Colon/Rectum
|
Colitis/Carcinoma
|
NR
|
2-6 months
|
|
no
|
97
|
|
Il-2 b2-microglobulin-/-
|
C57BL6 x 129
|
Rectum/Colon
|
Carcinoma
|
NR
|
6-12 months
|
|
no
|
98
|
Tcrα-/-
|
C57BL/6
|
Rectum/Colon
|
Colitis
|
NR
|
3-12 months
|
|
|
90
|
|
Gai2-/-
|
129Sv x C57BL/6J
|
Colon
|
Colitis/Carcinoma
|
1
|
3-9 months
|
altered thymocyte maturation
|
no
|
93
|
|
Carcinogen Treated
|
|
|
|
|
|
|
|
|
|
AOM
|
A/J
|
Colon
|
Adenoma/Carcinoma
|
36
|
6 months
|
|
NR
|
81
|
|
AOM
|
SWR/J
|
Colon
|
Adenoma/Carcinoma
|
16
|
6 months
|
|
NR
|
81
|
|
AOM
|
AKR/J
|
Colon
|
Adenoma/Carcinoma
|
<1
|
6 months
|
|
NR
|
81
|
|
MNU
|
NR
|
Small Intestine
|
Adenoma/Carcinoma
|
1.5
|
3-12 months
|
|
NR
|
76
|
|
MNG
|
C3H
|
Colon/ Small Intestine
|
Adenoma/Carcinoma
|
<1
|
11-20 months
|
Stomach SCC
|
NR
|
104
|
|
Other Models
|
|
|
|
|
|
|
|
|
|
Cdx2+/-
|
129/Sv x C57BL/6
|
Colon
|
gastric & intestinal
heterotopia
|
10
|
3 months
|
|
no
|
109
|
|
Muc2-/-
|
C57BL/6 x 129/SvOla
|
Small & Large Intestine
|
Adenoma/Carcinoma
|
1
|
6-12 months
|
|
no
|
111
|
|
PI(3)Kinaseg-/-
|
C57BL/6
|
Rectum/Colon
|
Carcinoma
|
1+
|
3-6 months
|
|
peritoneal
|
82
|
|
N-Cadherin-/-
|
C57BL/6 x 129/Sv
|
Small Intestine
|
Colitis/Adenoma
|
NR
|
2-19 months
|
|
no
|
110
|
NR= not reported, AOM=
Azoxymethane, MNU=N-methyl-N-nitrosourea, MNG= N-methyl-N-nitroso-N'nitroguanidine,
SCC=squamous cell carcinoma